M05.16

Clinical Causes: Autoimmune reaction: The immune system mistakenly attacks joint and lung tissues. Genetic predisposition: Certain genetic markers increase susceptibility to RA and associated lung disease. Environmental factors: Smoking and exposure to pollutants can contribute to lung involvement in RA. Disease progression: Chronic inflammation from RA can directly affect lung tissue over time. Medication effects: Long-term use of specific RA treatments may impact lung health.

Key Symptoms: Persistent cough, possibly with sputum production Shortness of breath or difficulty breathing, especially during exertion Chest pain or discomfort Fatigue and weakness Joint pain and swelling in the knees Fever or low-grade fever Reduced exercise tolerance

Diagnosis Path: Diagnosing rheumatoid lung disease involves a combination of clinical assessments and diagnostic tests, including: - Medical history review focusing on RA and lung symptoms - Physical examination - Chest X-ray to identify lung abnormalities - High-resolution computed tomography (HRCT) scans for detailed lung imaging - Pulmonary function tests (PFTs) to evaluate lung capacity and function - Blood tests to detect markers of inflammation and autoimmunity - Bronchoscopy or lung biopsy may be performed in certain cases to confirm diagnosis

Treatment Protocols: Managing rheumatoid lung disease with RA of the knee involves a multidisciplinary approach aimed at controlling inflammation and alleviating symptoms. Typical treatment strategies include: - Immunosuppressive medications: Disease-modifying antirheumatic drugs (DMARDs) and biologics to slow disease progression - Corticosteroids to reduce inflammation in lungs and joints - Symptomatic treatments: Oxygen therapy for breathing difficulties and pulmonary rehabilitation - Regular monitoring of lung function and RA activity - Lifestyle modifications: Smoking cessation and avoiding environmental pollutants - Physical therapy and exercise programs to maintain joint and respiratory health